Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Novalia Pishesha, Angelina M. Bilate, Marsha C. Wibowo, Nai Jia Huang, Zeyang Li, Rhogerry Dhesycka, Djenet Bousbaine, Hojun Li, Heide C. Patterson, Stephanie K. Dougan, Takeshi Maruyama, Harvey F. Lodish, Hidde L. Ploegh

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance might overcome these obstacles. Here we use the transpeptidase sortase to covalently attach diseaseassociated autoantigens to genetically engineered and to unmodified red blood cells as a means of inducing antigen-specific tolerance. This approach blunts the contribution to immunity of major subsets of immune effector cells (B cells, CD4+ and CD8+T cells) in an antigenspecific manner. Transfusion of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease in experimental autoimmune encephalomyelitis, as well as maintain normoglycemia in a mouse model of type 1 diabetes.

Original languageEnglish
Pages (from-to)3157-3162
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number12
DOIs
Publication statusPublished - 2017 Mar 21
Externally publishedYes

Fingerprint

Autoimmune Diseases
Erythrocytes
Peptidyl Transferases
Antigens
Erythrocyte Transfusion
Peptides
Autoimmune Experimental Encephalomyelitis
Opportunistic Infections
Autoantigens
Immunosuppressive Agents
Type 1 Diabetes Mellitus
Epitopes
Immunity
B-Lymphocytes
T-Lymphocytes
Therapeutics
To autoantigen

Keywords

  • Antigen-specific tolerance
  • Autoimmune diseases
  • Engineered red blood cells
  • Sortase

ASJC Scopus subject areas

  • General

Cite this

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. / Pishesha, Novalia; Bilate, Angelina M.; Wibowo, Marsha C.; Huang, Nai Jia; Li, Zeyang; Dhesycka, Rhogerry; Bousbaine, Djenet; Li, Hojun; Patterson, Heide C.; Dougan, Stephanie K.; Maruyama, Takeshi; Lodish, Harvey F.; Ploegh, Hidde L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 12, 21.03.2017, p. 3157-3162.

Research output: Contribution to journalArticle

Pishesha, N, Bilate, AM, Wibowo, MC, Huang, NJ, Li, Z, Dhesycka, R, Bousbaine, D, Li, H, Patterson, HC, Dougan, SK, Maruyama, T, Lodish, HF & Ploegh, HL 2017, 'Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 12, pp. 3157-3162. https://doi.org/10.1073/pnas.1701746114
Pishesha, Novalia ; Bilate, Angelina M. ; Wibowo, Marsha C. ; Huang, Nai Jia ; Li, Zeyang ; Dhesycka, Rhogerry ; Bousbaine, Djenet ; Li, Hojun ; Patterson, Heide C. ; Dougan, Stephanie K. ; Maruyama, Takeshi ; Lodish, Harvey F. ; Ploegh, Hidde L. / Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 12. pp. 3157-3162.
@article{6277e8b3bb1340b0929023f1e5ee7ac7,
title = "Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease",
abstract = "Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance might overcome these obstacles. Here we use the transpeptidase sortase to covalently attach diseaseassociated autoantigens to genetically engineered and to unmodified red blood cells as a means of inducing antigen-specific tolerance. This approach blunts the contribution to immunity of major subsets of immune effector cells (B cells, CD4+ and CD8+T cells) in an antigenspecific manner. Transfusion of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease in experimental autoimmune encephalomyelitis, as well as maintain normoglycemia in a mouse model of type 1 diabetes.",
keywords = "Antigen-specific tolerance, Autoimmune diseases, Engineered red blood cells, Sortase",
author = "Novalia Pishesha and Bilate, {Angelina M.} and Wibowo, {Marsha C.} and Huang, {Nai Jia} and Zeyang Li and Rhogerry Dhesycka and Djenet Bousbaine and Hojun Li and Patterson, {Heide C.} and Dougan, {Stephanie K.} and Takeshi Maruyama and Lodish, {Harvey F.} and Ploegh, {Hidde L.}",
year = "2017",
month = "3",
day = "21",
doi = "10.1073/pnas.1701746114",
language = "English",
volume = "114",
pages = "3157--3162",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

AU - Pishesha, Novalia

AU - Bilate, Angelina M.

AU - Wibowo, Marsha C.

AU - Huang, Nai Jia

AU - Li, Zeyang

AU - Dhesycka, Rhogerry

AU - Bousbaine, Djenet

AU - Li, Hojun

AU - Patterson, Heide C.

AU - Dougan, Stephanie K.

AU - Maruyama, Takeshi

AU - Lodish, Harvey F.

AU - Ploegh, Hidde L.

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance might overcome these obstacles. Here we use the transpeptidase sortase to covalently attach diseaseassociated autoantigens to genetically engineered and to unmodified red blood cells as a means of inducing antigen-specific tolerance. This approach blunts the contribution to immunity of major subsets of immune effector cells (B cells, CD4+ and CD8+T cells) in an antigenspecific manner. Transfusion of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease in experimental autoimmune encephalomyelitis, as well as maintain normoglycemia in a mouse model of type 1 diabetes.

AB - Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance might overcome these obstacles. Here we use the transpeptidase sortase to covalently attach diseaseassociated autoantigens to genetically engineered and to unmodified red blood cells as a means of inducing antigen-specific tolerance. This approach blunts the contribution to immunity of major subsets of immune effector cells (B cells, CD4+ and CD8+T cells) in an antigenspecific manner. Transfusion of red blood cells expressing self-antigen epitopes can alleviate and even prevent signs of disease in experimental autoimmune encephalomyelitis, as well as maintain normoglycemia in a mouse model of type 1 diabetes.

KW - Antigen-specific tolerance

KW - Autoimmune diseases

KW - Engineered red blood cells

KW - Sortase

UR - http://www.scopus.com/inward/record.url?scp=85016124849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016124849&partnerID=8YFLogxK

U2 - 10.1073/pnas.1701746114

DO - 10.1073/pnas.1701746114

M3 - Article

C2 - 28270614

AN - SCOPUS:85016124849

VL - 114

SP - 3157

EP - 3162

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -